Averna Therapeutics Appoints Robert Mabry as CSO and Richard Morris as CFO

Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, today announced the appointments of... Read More

The post Averna Therapeutics Appoints Robert Mabry as CSO and Richard Morris as CFO appeared first on citybiz.